Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Once-daily pill suppressed HBV viral load in nearly two thirds of people with HIV/HBV coinfection.
People with HIV are at greater risk for hepatitis B but are less likely to get vaccinated and respond to vaccines.
However, people who are not successfully treated may continue to experience declines in mental health.
Heavy alcohol use among people with hepatitis B or C increased the risk of liver cancer.
Physical activity also reduces the risk of comorbidities that occur at higher rates in people living with HIV.
Universal HCV testing led to an increase in the number of pregnant women and infants diagnosed in a timely manner.
Noninvasive imaging may be the best way to screen for NAFLD in this population.
The PreHevbrio vaccine produces higher antibody levels and offers faster protection.
People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.
However, no association was found between drinking coffee and liver fat accumulation.
With no approved treatments, management of NAFLD and NASH relies on lifestyle changes.
Barriers still stand in the way of making treatment available to all who need it.
The early cancer is detected, the easier it is to treat.
HIV was linked to an increased prevalence of liver fibrosis in a recent study.
Increased HCV testing and treatment for both HIV-positive and HIV-negative gay and bi men could help eliminate hep C.
People living with both viruses remain at risk for hepatocellular carcinoma despite antiviral therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.